Singapore markets closed

Kronos Bio, Inc. (KRON)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.0000+0.0200 (+2.04%)
As of 11:19AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-163,756
-112,673
-133,204
-151,078
-88,444
Depreciation & amortisation
2,238
2,136
2,266
1,977
839
Stock-based compensation
30,860
24,982
31,145
26,211
3,753
Change in working capital
-644
5,876
6,178
-1,620
6,460
Accounts payable
-2,136
-4,148
4,025
-3,195
2,807
Other working capital
-127,923
-79,261
-91,503
-122,184
-47,480
Other non-cash items
3,375
3,273
3,222
2,589
39,154
Net cash provided by operating activities
-126,920
-78,582
-90,926
-117,924
-37,912
Cash flows from investing activities
Investments in property, plant and equipment
-1,003
-679
-577
-4,260
-9,568
Purchases of investments
-321,300
-212,957
-367,124
-177,734
-229,328
Sales/maturities of investments
297,094
280,004
335,479
245,718
78,661
Net cash used for investing activities
-25,209
66,368
-32,222
63,724
-160,235
Cash flows from financing activities
Debt repayment
0
-
0
-5
-32
Common stock issued
-
-
-
0
263,725
Net cash used provided by (used for) financing activities
2,617
567
851
4,460
415,613
Net change in cash
-149,512
-11,647
-122,297
-49,740
217,466
Cash at beginning of period
219,019
77,999
200,296
250,036
32,570
Cash at end of period
69,507
66,352
77,999
200,296
250,036
Free cash flow
Operating cash flow
-126,920
-78,582
-90,926
-117,924
-37,912
Capital expenditure
-1,003
-679
-577
-4,260
-9,568
Free cash flow
-127,923
-79,261
-91,503
-122,184
-47,480